Filing Flows › Niagen Bioscience (NAGE) › Stock forecast & fair value
Niagen Bioscience (NAGE) stock forecast and price target
Niagen Bioscience (NAGE) trades at $2.07. 6 analysts' median price target is $10.00 (+383%), from $8.50 to $22.00.
Niagen Bioscience's latest quarter
Niagen Bioscience, Q3 2026: revenue $27.2M (-20% year over year), operating margin -5.8%, net loss $1.2M, operating cash flow $2.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for NAGE stock?
The median of 6 analysts' 12-month targets is $10.00, +383% from $2.07; the range is $8.50 to $22.00. The average rating is strong buy.
Does Niagen Bioscience usually beat earnings estimates?
It beat the consensus EPS estimate in 80% of the quarters on record.
Is NAGE stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.